Now showing items 1-6 of 6

    • The Case for Tailoring Patent Awards Based on the Time-to-Market of Inventions 

      Roin, Benjamin N. (University of California, 2013-05-08)
      One of the hallmarks of our patent system is that it provides a one-size-fits-all reward for innovation. Few deny a uniform 20-year patent term for all inventions provides too much protection for some, and too little for ...
    • The Disclosure Function of the Patent System (or Lack Thereof) 

      Roin, Benjamin N. (Harvard University, Harvard Law School, 2005)
    • Do Fixed Patent Terms Distort Innovation? Evidence from Cancer Clinical Trials 

      Budish, Eric; Roin, Benjamin Nathaniel; Williams, Heidi (National Bureau of Economic Research, 2013)
      Patents award innovators a fixed period of market exclusivity, e.g., 20 years in the United States. Yet, since in many industries firms file patents at the time of discovery (“invention”) rather than first sale (“commercia ...
    • Intellectual Property Versus Prizes: A Policy-Lever Analysis 

      Roin, Benjamin N. (2010)
      Most developed nations rely on intellectual property as one of their primary tools to promote private investments in R&D. An alternative approach is for the government to reward innovators with a prize instead of an ...
    • Solving the Problem of New Uses 

      Roin, Benjamin N. (Mich. St. L. Rev., 2014)
      One of the most dramatic public-policy failures in biomedical research is the lack of incentives for industry to develop new therapeutic uses (“indications”) for existing drugs once generics are available. Policymakers and ...
    • Unpatentable Drugs and the Standards of Patentability 

      Roin, Benjamin N. (University of Texas School of Law, 2009)
      The role of the patent system in promoting pharmaceutical innovation is widely seen as a tremendous success story. This view overlooks a serious shortcoming in the drug patent system: the standards by which drugs are deemed ...